✦ LIBER ✦

DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer

✍ Scribed by Robert A. Badalament; Joseph R. Drago; Robert V. O'Toole; Donn C. Young

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 918 KB
Volume: 67
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910615)67:12<3014::aid-cncr2820671215>3.0.co;2-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors for clinically locali

Prognostic factors for clinically localized prostate carcinoma : Analysis of 938 patients irradiated in the prostate specific antigen era

✍ Gunar K. Zagars; Alan Pollack; Andrew C. von Eschenbach 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

The Uniirradiated in the PSA era. versity of Texas, M. D. Anderson Cancer Center, ## METHODS. The authors analyzed the outcome for a group of 938 men with T1-T4,

DNA ploidy as a major prognostic factor

DNA ploidy as a major prognostic factor in resectable ampulla of vater cancers

✍ Dr. Yi-Ming Shyr; Cheng-Hsi Su; Li-Hwa Wu; Anna Fen-Yau Li; Jen-Hwey Chiu; Wing- 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

The archival paraffin-embedded specimens from 63 ampulla of Vater cancers after pancreaticoduodenectomy between 1965 and 199 I were analyzed by flow cytometry. Of the 63 cancers, 31 (49.2%) were diploid DNA cancers and 32 (50.8%) were aneuploid. Patients with diploid DNA cancer had a median survival

Monoclonal prostate-specific antigen in

Monoclonal prostate-specific antigen in untreated prostate cancer. Relationship to clinical stage and grade

✍ R. Joseph Babaian; Joseph L. Camps; Dino N. Frangos; Edilberto I. Ramirez; Denis 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

The authors evaluated 440 men with clinically staged and untreated prostate cancer with a monoclonal prostate-specific antigen (PSA) assay. The serum PSA value correlated significantly with both the stage and grade of disease (P < 0.00005). The relationships between PSA and consecutive Stages A, B,

Comparative analysis of prognostic facto

Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age

✍ Shockley, Kenneth F.; Maatman, Thomas J.; Carothers, George C.; Warzynski, Micha 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 2 views

One hundred consecutive men with adenocarcinoma of the prostate, treated by modified pelvic lymphadenectomy and radical retropubic prostatectomy, were evaluated, comparing DNA ploidy as determined by flow cytometry to surgical tumor stage (pT), preoperative prostatic specific antigen (PSA), Gleason

The chromatin remodeling factor SRCAP mo

The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells

✍ Artur Slupianek; Smitha Yerrum; Fayez F. Safadi; M. Alexandra Monroy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

## Abstract The SNF2‐related CBP activator protein (SRCAP) serves as a coactivator for several nuclear receptors including the androgen receptor (AR). SRCAP is an ATPase that is the core subunit of a large multiprotein complex and was shown to incorporate the histone variant H2A.Z into nucleosomes.

Intratumor heterogeneity of DNA ploidy a

Intratumor heterogeneity of DNA ploidy and correlations with clinical stage and histologic grade in prostate cancer

✍ Dr. Omer Kucuk; Taner Demirer; Alice Gilman-Sachs; Irene Taw; Michael Mangold; S 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

Paraffin blocks from 60 patients with prostate cancer were used to study the DNA ploidy patterns by flow cytometry. Nineteen patients had stage A disease, 11 had stage B, 9 had stage C , 20 had stage D, and 1 was of unknown stage. Histologically, 32 of the cancers were well differentiated, 2 1 were